Avail Clinical Research, LLC

Orange City, Florida 32763

0 studies enrolling now · 3 studies all time

What they study most

Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• 6-week Safety and PD Study in Adults With NAFLD — Completed